SENATORS COLLINS, SHAHEEN URGE FDA TO EXPAND ACCESS TO ISLET CELL TRANSPLANTATION FOR INDIVIDUALS WITH TYPE 1 DIABETES

WASHINGTON, June 18 -- Sen. Susan Collins issued the following press release:

U.S. Senators Susan Collins and Jeanne Shaheen (D-NH), co-chairs of the Senate Diabetes Caucus and lead sponsors of the bipartisan INSULIN Act (https://www.collins.senate.gov/newsroom/senators-collins-shaheen-warnock-kennedy-unveil-bipartisan-bill-to-cap-cost-of-insulin-at-35-per-month), are urging Acting Commissioner of the Food and Drug Administration (FDA) Kyle Diamantas to improve access to donor islet cell transplantation for certain individuals living with Type 1 Diabetes.

For many patients, donor islet cell transplantation can be life changing. Yet, despite rigorous scientific research showing the efficacy of the procedure and FDA approval of a donor isle...